Should we use Extracorporeal Photopheresis more often? Evidence from Graft-Versus-Host Disease Patients Monitored with Treg as a Biomarker

References

• LeeSJ. Classification systems for chronic graft-versus-host disease. Blood129(1), 30–37 (2017).
   PubMed Web of Science ®Google Scholar
• MartinPJ. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio. J. Med.57(4), 177–183 (2008).
   PubMedGoogle Scholar
• HartJW , ShiueLH , ShpallEJ , AlousiAM. Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion. Ther. Adv. Hematol.4(5), 320–334 (2013).
   PubMedGoogle Scholar
• KlassenJ. The role of photopheresis in the treatment of graft-versus-host disease. Curr. Oncol.17(2), 55–58 (2010).
   PubMed Web of Science ®Google Scholar
• MohammadiS , MalekMohammadi A , NorooznezhadAH , HeshmatiF , AlimoghaddamK , GhavamzadehA. Extra corporeal photochemotherapy in steroid refractory graft-versus-host disease: a review of guidelines and recommendations. Transfus. Apher. Sci.56(3), 376–384 (2017).
   PubMed Web of Science ®Google Scholar
• HeshmatiF. Updating ECP action mechanisms. Transfus. Apher. Sci.50(3), 330–339 (2014).
   PubMed Web of Science ®Google Scholar
• SpisekR , GasovaZ , BartunkovaJ. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion46(1), 55–65 (2006).
   PubMed Web of Science ®Google Scholar
• GorgunG , MillerKB , FossFM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood100(3), 941–947 (2002).
   PubMed Web of Science ®Google Scholar
• StadlerK , FreyB , MunozLEet al.Photopheresis with UV-A light and 8-methoxypsoralen leads to cell death and to release of blebs with anti-inflammatory phenotype in activated and non-activated lymphocytes. Biochem. Biophys. Res. Commun.386(1), 71–76 (2009).
   PubMed Web of Science ®Google Scholar
• HannaniD. Extracorporeal photopheresis: tolerogenic or immunogenic cell death? Beyond current dogma. Front. Immunol.6, 349 (2015).
   PubMed Web of Science ®Google Scholar
• Abu-DalleI , ReljicT , NishihoriTet al.Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies. Biol. Blood Marrow Transplant.20(11), 1677–1686 (2014).
   PubMed Web of Science ®Google Scholar
• AliAM , DipersioJF , SchroederMA. The role of biomarkers in the diagnosis and risk stratification of acute graft-versus-host disease: a systematic review. Biol. Blood Marrow Transplant.22(9), 1552–1564 (2016).
   PubMed Web of Science ®Google Scholar
• PidalaJ , SigdelTK , WangAet al.A combined biomarker and clinical panel for chronic graft-versus-host disease diagnosis. J. Pathol. Clin. Res.3(1), 3–16 (2017).
   PubMedGoogle Scholar
• TsirigotisP , KapsimalliV , BaltadakisIet al.Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology. Transfus. Apher. Sci.46(2), 181–188 (2012).
   PubMed Web of Science ®Google Scholar
• BergerM , AlbianiR , SiniB , FagioliF. Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study. Transfusion55(4), 736–747 (2015).
   PubMed Web of Science ®Google Scholar
• BrosigA , HahnelV , OrsoE , WolffD , HollerE , AhrensN. Technical comparison of four different extracorporeal photopheresis systems. Transfusion56(10), 2510–2519 (2016).
   PubMed Web of Science ®Google Scholar
• Dall'AmicoR , ZulianF , MontiniGet al.Applications of extracorporeal photochemotherapy in “non-oncological” diseases. Int. J. Artif. Organs16(Suppl. 5), 168–172 (1993).
   PubMedGoogle Scholar
• OwsianowskiM , GollnickH , SiegertW , SchwerdtfegerR , OrfanosCE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant.14(5), 845–848 (1994).
   PubMed Web of Science ®Google Scholar
• HamblinMR. Ultraviolet irradiation of blood: “the cure that time forgot”?Adv. Exp. Med. Biol.996, 295–309 (2017).
   PubMed Web of Science ®Google Scholar
• WeitzM , StrahmB , MeerpohlJJ , SchmidtM , BasslerD. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. Cochrane Database Syst. Rev.2015(12), CD009898 (2015).
   PubMedGoogle Scholar
• BredesonC , RumbleRB , VarelaNP , KuruvillaJ , KouroukisCT. Stem Cell Transplant Steering C. Extracorporeal photopheresis in the management of graft-versus-host disease. Curr. Oncol.21(2), e310–325 (2014).
   PubMed Web of Science ®Google Scholar
• DippelE , GoerdtS , OrfanosCE. Long-term extracorporeal photoimmunotherapy for treatment of chronic cutaneous graft-versus-host disease: observations in four patients. Dermatology198(4), 370–374 (1999).
   PubMed Web of Science ®Google Scholar
• de WaureC , CapriS , VenezianoMAet al.Extracorporeal photopheresis for second-line treatment of chronic graft-versus-host diseases: results from a health technology assessment in Italy. Value Health18(4), 457–466 (2015).
   PubMed Web of Science ®Google Scholar
• KariminiaA , IvisonS , NgBet al.CD56 bright NK regulatory cells in filgrastim primed donor blood or marrow products regulate chronic GvHD: CBMTG randomized 0601 study results. Haematologica102, 1936– 1946 (2017).
   PubMed Web of Science ®Google Scholar
• BuddeH , BerntschU , RiggertJ , LeglerTJ. In vitro effects of different 8-methoxypsoralen treatment protocols for extracorporeal photopheresis on mononuclear cells. Cent. Eur. J. Immunol.42(1), 1–9 (2017).
   PubMed Web of Science ®Google Scholar
• LiuW , PutnamAL , Xu-YuZet al.CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med.203(7), 1701–1711 (2006).
   PubMed Web of Science ®Google Scholar
• SeddikiN , Santner-NananB , MartinsonJet al.Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med.203(7), 1693–1700 (2006).
   PubMed Web of Science ®Google Scholar
• RubegniP , SbanoP , CeveniniGet al.CD4 + CD25+ lymphocyte subsets in chronic graft-versus-host disease patients undergoing extracorporeal photochemotherapy. Int. J. Immunopathol. Pharmacol.20(4), 801–807 (2007).
   PubMed Web of Science ®Google Scholar
• DenneyHA , WhittleRJ , LaiJ , JacquesRM , TaylorPC. Regulatory T cells in chronic graft-versus-host disease after extracorporeal photopheresis: correlation with skin and global organ responses, and ability to taper steroids. Transplantation101(1), 204–211 (2017).
   PubMed Web of Science ®Google Scholar
• GandelmanJS , SongDJ , ChenHet al.A prospective trial of extracorporeal photopheresis for chronic graft-versus-host disease reveals significant disease response and no association with frequency of regulatory T cells. Biol. Blood Marrow Transplant.24(12), 2373–2380 (2018).
   PubMed Web of Science ®Google Scholar